Nivolumab
PD-1 immunotherapy, often combined with ipilimumab.
- Starts working
- Varies
- Half-life
- About 25 days
- In use since
- 2014
- Pregnancy
- Usually avoided
Overview
Nivolumab (Opdivo) is a PD-1 immunotherapy used in melanoma, lung, kidney, oesophageal, bladder and other cancers, often alongside ipilimumab or chemotherapy. Its immune side effects resemble pembrolizumab's.
Conditions it's used for
How it works
Releases a brake on immune cells so they attack cancer.
Nivolumab belongs to the Immune checkpoint inhibitors. How Immune checkpoint inhibitors work: remove a brake cancer cells use to hide from T-cells, so the immune system attacks the tumour. Side effects come from the immune system attacking healthy organs.
Uses
- Melanoma
- Lung cancer
- Kidney cancer
- Oesophageal and stomach cancer
- Hodgkin lymphoma
- Bowel cancer (MSI-high)
Available as: iv infusion, subcutaneous injection.
Typical dose
- Adults
- 240 mg every 2 weeks or 480 mg every 4 weeks IV.
Typical doses for orientation only. Your prescription, the pack leaflet and local guidance take priority.
Side effects
Common
Often mild and may settle with time
- Tiredness
- Rash
- Diarrhoea
- Thyroid problems
Serious — get medical help
Uncommon, but need prompt attention
- Pneumonitis
- Colitis
- Hepatitis
- Endocrine failure
Warnings
- Report new symptoms promptly
Interactions
- Systemic steroids before starting
Pregnancy and breastfeeding
Usually avoided
Contraception needed.
Breastfeeding advice can differ from pregnancy advice — check with a pharmacist, or the LactMed database.
Brand names
- United States
- Opdivo, Opdivo Qvantig
- United Kingdom
- Opdivo
- India
- Opdyta, Opdivo
- Australia
- Opdivo
Examples only; many generic versions exist. The same brand name can mean different products in different countries.
Common questions
Why combine it with ipilimumab?
Blocking two different brakes (PD-1 and CTLA-4) boosts response in some cancers, at the cost of more side effects.
Do I need a prescription for Nivolumab?
Yes — Nivolumab is prescription-only in most countries.
Can I take Nivolumab during pregnancy?
Usually avoided. Contraception needed. Always check with a doctor or midwife.
Related medicines
Pembrolizumab
Immunotherapy for many cancers — the world's top-selling medicine.
RxWHOImmune checkpoint inhibitorsRituximab
Antibody that clears B-cells — for lymphoma and autoimmune disease.
RxWHOTargeted antibodiesBevacizumab
Cuts off a tumour's blood supply.
RxTargeted antibodiesAtezolizumab
PD-L1 checkpoint inhibitor given by infusion.
RxImmune checkpoint inhibitors
Sources and official information
- MedlinePlus (US National Library of Medicine)
- DailyMed — official US labels
- NHS medicines A–Z
- WHO ATC/DDD index — L01FF01
Entry last reviewed October 2026. Compiled from WHO, NHS, FDA/DailyMed, BNF and national formulary information. How we write entries.